Description

Tirzepatide 60mg

Tirzepatide 60mg is a premium research peptide developed to support scientific investigations involving glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor signaling. As a dual incretin receptor agonist, Tirzepatide has become an important tool for studying complex metabolic pathways, energy homeostasis, and endocrine communication.

Researchers continue to investigate Tirzepatide in laboratory models examining glucose regulation, insulin secretion, glucagon signaling, gastric emptying, lipid metabolism, appetite regulation, and intracellular signaling mechanisms. Dual activation of GIP and GLP-1 receptors provides opportunities to study coordinated physiological responses that differ from selective receptor activation alone.

Cellular Genix Labs manufactures Tirzepatide 60mg using advanced solid-phase peptide synthesis (SPPS) and stringent quality-control procedures to deliver a consistent research-grade product suitable for reproducible laboratory investigations.

Research Applications

Tirzepatide 60mg is commonly investigated in research involving:

• Dual GIP and GLP-1 receptor activation
• Incretin hormone biology
• Metabolic signaling pathways
• Glucose homeostasis
• Insulin secretion mechanisms
• Glucagon regulation
• Energy expenditure research
• Appetite and satiety signaling
• Lipid metabolism
• Pancreatic islet biology
• Endocrine physiology
• Cellular receptor pharmacology
• Cardiometabolic research models

Product Specifications

• Compound: Tirzepatide
• Quantity: 60mg
• Purity: ≥99% (HPLC/MS Verified)
• Appearance: White to off-white lyophilized powder
• Sequence: 39-amino acid synthetic peptide
• Form: Lyophilized peptide
• Grade: Research Grade
• Storage: Store refrigerated at 2–8°C. For long-term storage, store frozen at −20°C. Protect from light, heat, moisture, and repeated freeze-thaw cycles.
  

  Scientific Background

  Tirzepatide has become one of the most extensively studied dual incretin receptor agonists in metabolic research. By activating both GIP and GLP-1 receptors, it allows investigators to examine coordinated signaling pathways involved in glucose metabolism, insulin sensitivity, gastrointestinal hormone activity, adipose tissue biology, hepatic metabolism, and whole-body energy regulation.

  Current laboratory research also explores:

  • Intracellular signaling cascades
  • Receptor desensitization and adaptation
  • β-cell physiology
  • Adipocyte function
  • Mitochondrial energy metabolism
  • Cardiometabolic signaling
  • Inflammation associated with metabolic disorders
  • Long-term metabolic regulation

  These investigations continue to expand scientific understanding of incretin biology and endocrine physiology.